Clinical Trial: A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07728097) titled 'A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS' on July 22.

Brief Summary: This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS in adults.

Study Start Date: Nov. 18, 2026

Study Type: INTERVENTIONAL

Condition: Lennox-Gastaut Syndrome

Intervention: DRUG: Cannabidiol Oral Solution

100 mg/ml Cannabidiol Oral solution (CBD-OS)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jazz Pharmaceuticals

Disclaimer: Curated by HT Syndication....